Safety of lurasidone in adolescents with schizophrenia: Interim analysis of a 24-month, open-label extension study

Authors
Category Primary study
JournalEuropean Neuropsychopharmacology
Year 2017
This article has no abstract
Epistemonikos ID: b6ef4e315a1aea5930a4184c936e8423b3f4f20b
First added on: Feb 08, 2025